OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. A variety of strategies have been employed maximize antibody titer, including process parameter optimization, cell line development, and adoption of perfusion systems. Fine-tuning growth p